Heron Therapeutics (HRTX) Q3 2024 Earnings

Aug 6Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.29
-0.2
-0.11
-0.02

Details

Expected EPS
-0.0393
Actual EPS
-0.06
Surprise EPS
-0.02
Surprise Percent
-52.67%

Description

⁨Heron Therapeutics⁩ (⁦HRTX⁩) has reported earnings of ⁦-0.06⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts